Covered recipient · General Payments record
ALLEN S LIM JR
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2023
$8,066.86
- Reported across 454 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,033.05 | 55 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $105.87 | 7 |
| Merck Sharp & Dohme Corporation | $92.01 | 5 |
| PFIZER INC. | $73.95 | 4 |
| GENZYME CORPORATION | $69.48 | 3 |
| Regeneron Healthcare Solutions, Inc. | $68.42 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $67.97 | 4 |
| E.R. Squibb & Sons, L.L.C. | $64.15 | 4 |
| Janssen Biotech, Inc. | $55.96 | 3 |
| Exelixis Inc. | $36.80 | 2 |
| ARRAY BIOPHARMA INC | $35.01 | 2 |
| Lilly USA, LLC | $34.81 | 2 |
| Amgen Inc. | $32.53 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.31 | 1 |
| Stemline Therapeutics Inc. | $24.92 | 1 |
| SEAGEN INC. | $23.47 | 1 |
| ADC Therapeutics America, Inc. | $20.45 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.17 | 1 |
| PharmaEssentia USA Corporation | $19.89 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $19.85 | 1 |
| Daiichi Sankyo Inc. | $19.51 | 1 |
| Astellas Pharma US Inc | $19.48 | 1 |
| Blueprint Medicines Corporation | $17.72 | 1 |
| Pharmacyclics LLC, An AbbVie Company | $17.58 | 1 |
| Acerta Pharma LLC | $17.38 | 1 |
| BeiGene USA, Inc. | $17.25 | 1 |
| AVEO Pharmaceuticals, Inc. | $15.56 | 1 |
| Ipsen Biopharmaceuticals, Inc | $13.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (55)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.